Northrop Grumman (NOC) Q3 2025 Financial Results Summary

0
6

Northrop Grumman (NOC) Q3 2025 Financial Results Summary

Release Date: October 21, 2025

Northrop Grumman Corporation (NYSE: NOC) reported strong financial results for the third quarter of 2025, highlighting growth across several key metrics. Below is a summary of the key financial results and insights from the earnings report.

Key Financial Highlights

  • Net Awards: $12.2 billion, resulting in a book-to-bill ratio of 1.17.
  • Sales: Increased by 4% to $10.4 billion from $10.0 billion in Q3 2024.
  • Organic Sales: Grew by 5% to $10.4 billion.
  • Operating Margin Rate: Improved to 11.9%, up from 11.2% a year ago.
  • Segment Operating Margin Rate: Increased to 12.3% from 11.5%.
  • Diluted Earnings Per Share (EPS): Increased by 10% to $7.67 compared to $7.00 in Q3 2024.
  • 2025 MTM-Adjusted EPS Guidance: Raised by $0.65 to a range of $25.65 to $26.05.

Consolidated Operating Results

Total Sales Breakdown (Q3 2025 vs. Q3 2024)

  • Aeronautics Systems:
  • Sales: $3.142 billion (up 6%)
  • Operating Income: $305 million (down 1%)
  • Operating Margin Rate: 9.7% (down from 10.4%)

  • Defense Systems:

  • Sales: $2.059 billion (up 14%)
  • Operating Income: $234 million (up 46%)
  • Operating Margin Rate: 11.4% (up from 8.9%)

  • Mission Systems:

  • Sales: $3.093 billion (up 10%)
  • Operating Income: $515 million (up 32%)
  • Operating Margin Rate: 16.7% (up from 13.8%)

  • Space Systems:

  • Sales: $2.698 billion (down 6%)
  • Operating Income: $298 million (down 14%)
  • Operating Margin Rate: 11.0% (down from 12.0%)

Cash Flow Highlights

  • Net Cash Provided by Operating Activities: Increased 43% to $1.557 billion compared to $1.091 billion in Q3 2024.
  • Free Cash Flow: Rose 72% to $1.256 billion from $730 million in Q3 2024.
  • Capital Expenditures: Decreased by 17% to $301 million compared to $361 million.

Financial Position

  • Total Assets: $49.3 billion, slightly down from $49.4 billion as of December 31, 2024.
  • Total Liabilities: Decrease to $33.3 billion from $34.1 billion.
  • Shareholders’ Equity: Increased to $16.0 billion from $15.3 billion.

Share Repurchase and Dividends

  • Common Stock Repurchases: Totaled $1.168 billion for the quarter.
  • Dividends Paid: Amounted to $964 million.

Awards and Backlog

  • Backlog Total: Stands at $91.4 billion.
  • Major New Awards: Included significant contracts valued at $4.5 billion for restricted programs, $1.8 billion for the Ground-Based Midcourse Defense Weapon System, and additional contracts for F-35 and Virginia Class submarines.

Guidance for 2025

  • Sales Guidance: Expected sales range of $41.7 billion to $41.9 billion (previously $42.05 billion to $42.25 billion).
  • Segment Operating Income Guidance: Projected range of $4.275 billion to $4.375 billion.
  • Free Cash Flow Guidance: Anticipates between $3.050 billion to $3.350 billion.

This summary encapsulates Northrop Grumman’s robust performance in the third quarter of 2025, showcasing a solid increase in sales, operating income, and overall financial strength while also emphasizing its ongoing commitment to returning value to shareholders through dividends and share repurchases.

$ in millions, except per share amounts Three Months Ended September 30 2025 2024 Nine Months Ended September 30 2025 2024
Sales Product $8,369 $7,939 $24,148 $24,117
Service 2,054 2,057 6,094 6,230
Total sales 10,423 9,996 30,242 30,347
Operating costs and expenses Product 6,631 6,280 19,523 19,079
Service 1,565 1,610 4,702 4,838
General and administrative expenses 985 986 3,008 3,149
Total operating costs and expenses 9,181 8,876 27,233 27,066
Gain on sale of business 231
Operating income 1,242 1,120 3,240 3,281
Other (expense) income Interest expense -161 -161 -490 -461
Non-operating FAS pension benefit 136 168 403 503
Other, net 106 61 175 142
Earnings before income taxes 1,323 1,188 3,328 3,465
Federal and foreign income tax expense 223 162 573 555
Net earnings $1,100 $1,026 $2,755 $2,910
Basic earnings per share $7.69 $7.02 $19.16 $19.73
Weighted-average common shares outstanding, in millions 143.1 146.2 143.8 147.5
Diluted earnings per share $7.67 $7.00 $19.12 $19.69
Weighted-average diluted shares outstanding, in millions 143.5 146.5 144.1 147.8
Net earnings (from above) $1,100 $1,026 $2,755 $2,910
Other comprehensive income (loss), net of tax Change in cumulative translation adjustment 2 2 11 2
Change in other, net -1 8 18 -10
Other comprehensive income (loss), net of tax 1 10 29 -8
Comprehensive income $1,101 $1,036 $2,784 $2,902
$ in millions September 30, 2025 December 31, 2024
Assets Cash and cash equivalents $1,957 $4,353
Accounts receivable, net 1,983 1,272
Unbilled receivables, net 7,030 5,908
Inventoried costs, net 1,615 1,455
Prepaid expenses and other current assets 1,520 1,286
Total current assets 14,105 14,274
Property, plant and equipment, net of accumulated depreciation of $9,430 for 2025 and $8,733 for 2024 10,542 10,536
Operating lease right-of-use assets 1,783 1,770
Goodwill 17,436 17,512
Intangible assets, net 220 254
Deferred tax assets 1,255 1,599
Pension and other postretirement benefit plan assets 2,501 2,184
Other non-current assets 1,458 1,230
Total assets $49,300 $49,359
Liabilities Trade accounts payable $2,797 $2,599
Accrued employee compensation 1,946 2,271
Advance payments and billings in excess of costs incurred 3,562 4,070
Other current liabilities 4,413 5,188
Total current liabilities 12,718 14,128
Long-term debt, net of current portion of $533 for 2025 and $1,582 for 2024 15,162 14,692
Pension and other postretirement benefit plan liabilities 1,100 1,120
Operating lease liabilities 1,796 1,798
Other non-current liabilities 2,536 2,331
Total liabilities 33,312 34,069
Shareholders’ equity Preferred stock, $1 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $1 par value; 800,000,000 shares authorized; issued and outstanding: 2025—142,790,278 and 2024—144,952,026 143 145
Paid-in capital
Retained earnings 15,968 15,297
Accumulated other comprehensive loss -123 -152
Total shareholders’ equity 15,988 15,290
Total liabilities and shareholders’ equity $49,300 $49,359